FULCRUM THERAPEUTICS, INC. EXECUTIVEEMPLOYMENT AGREEMENTExecutiveemployment Agreement • November 7th, 2023 • Fulcrum Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is made as of August 7, 2023 (the “Effective Date”) by and between Fulcrum Therapeutics, Inc. (the “Company”) and Alan Musso (the “Executive”) (the Company and the Executive each a “Party” and together the “Parties”).
CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL LICENSE AGREEMENT between CAMP4 THERAPEUTICS CORP. and...License Agreement • November 7th, 2023 • Fulcrum Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This License Agreement (“Agreement”) is entered into as of July 5th, 2023 (the “Effective Date”) by and between CAMP4 Therapeutics Corporation, a corporation organized and existing under the laws of Delaware, with its principal business office located at One Kendall Square, Bldg 1400 West, 3rd Floor, Cambridge, MA 02139, U.S.A. (“CAMP4”), and Fulcrum Therapeutics, Inc., a corporation organized and existing under the laws of Massachusetts, with its principal business office located at 26 Landsdowne Street Cambridge, MA 02139, U.S.A. (“Fulcrum”). Fulcrum and CAMP4 are each hereafter referred to individually as a “Party” and together as the “Parties.”
